Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Finished Goods (2025 - 2026)

Updated

Impact Biomedical (IBO) reported Finished Goods of $56,000 for Q3 2026, down 88.5% from $485,000 a year earlier and down 9.7% from the prior quarter.

Analysis

Impact Biomedical (IBO) Finished Goods (2025 - 2026) Analysis & Trends

At the end of FY2025, Impact Biomedical posted Finished Goods of $63,000.

  • Per Business Quant data, the three quarters before Q3 2026 came in at $62,000 (Q2 2026), $63,000 (Q1 2026) and $63,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 56,000.00
Jun 30, 2026 62,000.00
Mar 31, 2026 63,000.00
Dec 31, 2025 63,000.00
Sep 30, 2025 485,000.00
Jun 30, 2025 486,000.00
API Access

Impact Biomedical Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=IBO&period=max&api_key=YOUR_API_KEY